Phase 2a Study Evaluating a Chemokine-Modulatory Regimen in Patients With Colorectal Cancer Metastatic to the Liver
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 12 Feb 2018
At a glance
- Drugs Celecoxib (Primary) ; Interferon alpha-2b (Primary) ; Rintatolimod (Primary)
- Indications Colorectal cancer; Liver metastases
- Focus Pharmacodynamics
- 08 Feb 2018 Planned initiation date changed from 1 Feb 2018 to 1 Mar 2018.
- 22 Jan 2018 Phase has been changed from Phase 0 to Phase 2A.
- 22 Jan 2018 New trial record